Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care * an implementation pilot - Diabetyping & lifestyle as a medicine

TNO0 个研究点目标入组 16 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•The participants will be recruited from the T2D patient population of healthcare partnership Stevenshof. Four GPA*s work for healthcare partnership Stevenshof. Each GPA will select two T2D patients in each of the two study phases. These patients should meet one of the following requirements:
•- Patient is newly diagnosed with T2D
•- Patient is about to start Metformin
•- Patient is about to start with a second oral drug (like SU-derivates)
•- Patient is about to start with an injectable drug (Insulin or GLP-1);Besides that, the patients should meet the following inclusion criteria:
•- Aged between 30-80
•- Have a BMI between 25-35
•- Willing and able to sign the informed consent form
•- Able to fill in the 360-degree questionnaire which is in Dutch
•- Able to work with computers (e.g. for filling in digital questionnaires)

•A candidate who meets any of the following criteria will be excluded from participation in this study:
•- Dialysis patients
•- Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
•- Patients under treatment of a psychiatrist
•- Incapacitated patients
•- Patients in a palliative phase

发起方

TNO